Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/49.2.367PMID 11815581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Typing of Listeria monocytogenes isolates by random amplification of polymorphic DNA.

  2003cited by this paper
• Epidemiological Survey of Amoxicillin-Clavulanate Resistance and Corresponding Molecular Mechanisms in Escherichia coliIsolates in France: New Genetic Features ofblaTEM Genes

  2000cited by this paper
• Risk Factors for Recovery of Ampicillin-Sulbactam-Resistant Escherichia coli in Hospitalized Patients

  2000cited by this paper
• Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

  1999cited by this paper
• Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.

  1999cited by this paper
• Discriminatory Detection of Inhibitor-Resistant β-Lactamases in Escherichia coli by Single-Strand Conformation Polymorphism-PCR

  1998cited by this paper
• Guidelines for management of adult community-acquired lower respiratory tract infections

  1998cited by this paper
• Trends in antimicrobial drug use in the community--France, 1981-1992.

  1998cited by this paper
• Typing of Clostridium perfringens strains by use of Random Amplified Polymorphic DNA (RAPD) system in comparison with zymotyping.

  1997cited by this paper
• Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms.

  1996cited by this paper
• Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli

  1995cited by this paper
• Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

  1995cited by this paper
• Use of molecular analysis in pathophysiological investigation of late-onset neonatal Escherichia coli meningitis

  1995cited by this paper
• Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2).

  1994cited by this paper
• Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.

  1994cited by this paper
• Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors

  1994cited by this paper
• Typing of Listeria strains by random amplification of polymorphic DNA.

  1992cited by this paper
• Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli

  1989cited by this paper
• Augmentin: Laboratory Studies

  1982cited by this paper
• Received

  1868cited by this paper

• Reflecting on Fleming’s caveat: the impact of stakeholder decision-making on antimicrobial resistance evolution

  2025cites this paper
• E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community

  2022cites this paper
• Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by Escherichia coli or Klebsiella pneumoniae: The Role of Prior Exposure to Fluoroquinolones

  2021cites this paper
• Antibiotic resistance in paediatric UTIs in Norway

  2021cites this paper
• Insight into the screening of potential beta-lactamase inhibitors as anti-bacterial chemical agents through pharmacoinformatics study

  2020cites this paper
• Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy

  2020cites this paper
• Distribution of integrons and phylogenetic groups among Escherichia coli causing community-acquired urinary tract infection in Upper Egypt.

  2020cites this paper
• Improving the quality of antibiotic prescribing through an educational intervention delivered through the out-of-hours general practice service in Ireland

  2020cites this paper
• Surveillance and Detection of Inhibitor-Resistant Beta-Lactamases in Clinical Isolates of Escherichia coli

  2017cites this paper
• Pharmacokinetics and pharmacodynamics in antibiotic dose optimization

  2016cites this paper
• Molecular epidemiological study of extended spectrum betalactamase (ESBL) producing bacteria from teaching and district general hospitals within Hampshire

  2015cites this paper
• Sensibilité de 291 souches de Escherichia coli urinaires à l’amoxicilline-acide clavulanique : quels résultats pour quelles méthodes ?

  2015cites this paper
• A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance

  2014cites this paper
• Insight into the Effect of Inhibitor Resistant S130G Mutant on Physico-Chemical Properties of SHV Type Beta-Lactamase: A Molecular Dynamics Study

  2014cites this paper
• Antibiotic Prescribing in Primary Care and Antimicrobial Resistance in Patients Admitted to Hospital with Urinary Tract Infection: A Controlled Observational Pilot Study

  2014cites this paper
• Dynamic drug combination methods for suppressing bacterial antibiotics resistance adaptation

  2014cites this paper
• Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India

  2014cites this paper
• Prevalence of Multidrug Resistant E. Coli in the river Mahanadi of Sambalpur

  2013cites this paper
• Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.

  2012cites this paper
• Adverse Outcomes in Nursing Home Residents with Increased Episodes of Observed Bacteriuria

  2011cites this paper
• In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli.

  2011cites this paper
• Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.

  2010cites this paper
• Three Decades of β-Lactamase Inhibitors

  2010cites this paper
• Inhibition of Class A and C β-Lactamases: Challenges and Promise

  2010cites this paper
• Previous Antimicrobial Exposure Is Associated With Drug-Resistant Urinary Tract Infections in Children

  2010cites this paper
• IRT and CMT β‐lactamases and inhibitor resistance

  2008cites this paper
• Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study

  2008cites this paper
• IRT and CMT beta-lactamases and inhibitor resistance.

  2008cites this paper
• Increased Amoxicillin–Clavulanic Acid Resistance in Escherichia coli Blood Isolates, Spain

  2008cites this paper
• Antibiothérapie probabiliste en pratique de ville

  2008cites this paper
• [Evaluation of amoxicillin-clavulanic acid prescriptions in a teaching hospital of Parisian suburb].

  2008cites this paper
• Antibioticoterapia probabilística en la práctica ambulatoria

  2008cites this paper
• Antibioticoterapia probabilista nella pratica cittadina

  2008cites this paper
• Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases.

  2007cites this paper
• Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.

  2007cites this paper
• Genotyping of Extended Spectrum Β-Lactamase Escherichia Coli Strains from Clinical Specimens

  2006cites this paper
• Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.

  2005cites this paper
• (cid:2) -Lactamase-Producing Nontypeable Haemophilus influenzae Fails To Protect Streptococcus pneumoniae from Amoxicillin during Experimental Acute Otitis Media

  2004cites this paper
• β-Lactamase-Producing Nontypeable Haemophilus influenzae Fails To Protect Streptococcus pneumoniae from Amoxicillin during Experimental Acute Otitis Media

  2004cites this paper
• Emergence and Spread of Three Clonally Related Virulent Isolates of CTX-M-15-Producing Escherichia coli with Variable Resistance to Aminoglycosides and Tetracycline in a French Geriatric Hospital

  2004cites this paper
• Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.

  2004cites this paper
• Variety of β-Lactamases Produced by Amoxicillin-Clavulanate-Resistant Escherichia coli Isolated in the Northeastern United States

  2004cites this paper
• No significant decrease in antibiotic use from 1992 to 2000, in the French community.

  2004cites this paper
• Impact of changing patterns of anti-microbial resistance in uropathogens: Emerging treatment and strategies

  2003cites this paper
• Facteurs de risque d’infection à Escherichia coli résistant à l’amoxicilline–acide clavulanique en réanimation

  2003cites this paper
• The current management strategies for community-acquired urinary tract infection.

  2003cites this paper
• HIV infection and AIDS Test for mitochondrial function and DNA: potential and pitfalls Related review: Tests for mitochondrial function and DNA: potentials and pitfalls (pp 5–10)

  2003cites this paper
• Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study

  2003cites this paper
• [Risk factors for amoxicillin-clavulanate-resistant Escherichia coli in ICU patients].

  2003cites this paper